# Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome

> **NCT01781234** · PHASE2 · COMPLETED · sponsor: **Ajna Hamidovic** · enrollment: 51 (actual)

## Conditions studied

- Tobacco Abstinence Syndrome

## Interventions

- **DRUG:** Intranasal Insulin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01781234
- **Lead sponsor:** Ajna Hamidovic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2018-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781234, "Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01781234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*